Clinical trial
UT-15C SR in the Treatment of Critical Limb Ischemia
NCT00445159 · Southern Arizona Vascular Institute, Other · Unknown status
Key facts
| NCT number | NCT00445159 |
|---|---|
| Title | UT-15C SR in the Treatment of Critical Limb Ischemia |
| Official title | An Investigator Initiated Eight Week Two Center Open-Label Pilot Study of the Tolerability and Safety of Oral UT-15C (Treprostinil Diethanolamine)SR Tablets in Patients With Critical Limb Ischemia (CLI) and Ischemic Rest Pain |
| Lead sponsor | Southern Arizona Vascular Institute, Other |
| Collaborators | Southern Illinois University |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Critical Limb Ischemia |
| Intervention type | Drug |
| Interventions | UT-15C SR (treprostinil diethanolamine) 1mg oral tablets |
| Enrollment | 20 |
| Start date | Nov 1, 2006 |
| First posted | Mar 8, 2007 |
| Last update posted | Mar 8, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: